CY1549A - Naphthoquinone derivatives - Google Patents

Naphthoquinone derivatives

Info

Publication number
CY1549A
CY1549A CY1549A CY154991A CY1549A CY 1549 A CY1549 A CY 1549A CY 1549 A CY1549 A CY 1549A CY 154991 A CY154991 A CY 154991A CY 1549 A CY1549 A CY 1549A
Authority
CY
Cyprus
Prior art keywords
alkyl
naphthoquinone derivatives
alkoxy
halogen
naphthoquinone
Prior art date
Application number
CY1549A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CY1549A publication Critical patent/CY1549A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30—Unsaturated compounds
    • C07C62/34—Unsaturated compounds containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00—Preparation of quinones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/32—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/08—Saturated compounds having a carboxyl group bound to a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/15—Saturated compounds containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16—Unsaturated compounds
    • C07C61/39—Unsaturated compounds containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16—Unsaturated compounds
    • C07C61/40—Unsaturated compounds containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/08—Saturated compounds containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/08—Saturated compounds containing ether groups, groups, groups, or groups
    • C07C62/10—Saturated compounds containing ether groups, groups, groups, or groups with a six-membered ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY1549A 1983-04-14 1991-03-22 Naphthoquinone derivatives CY1549A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838310141A GB8310141D0 (en) 1983-04-14 1983-04-14 Naphthoquinone derivatives

Publications (1)

Publication Number Publication Date
CY1549A true CY1549A (en) 1991-03-22

Family

ID=10541105

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1549A CY1549A (en) 1983-04-14 1991-03-22 Naphthoquinone derivatives

Country Status (17)

Country Link
EP (1) EP0123238B1 (ja)
JP (1) JPS59205341A (ja)
AT (1) ATE27696T1 (ja)
AU (1) AU574353B2 (ja)
CY (1) CY1549A (ja)
DE (2) DE3464132D1 (ja)
DK (1) DK172273B1 (ja)
GB (1) GB8310141D0 (ja)
HK (1) HK56690A (ja)
IL (1) IL71545A (ja)
LU (1) LU88579I2 (ja)
MX (1) MX9202993A (ja)
MY (1) MY102117A (ja)
NL (1) NL950002I2 (ja)
PH (1) PH22018A (ja)
SG (1) SG39390G (ja)
ZA (1) ZA842797B (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
US5175319A (en) * 1983-04-14 1992-12-29 Burroughs Wellcome Co. Naphthoquinone derivatives
EP0253501A3 (en) * 1986-07-16 1990-04-04 Imperial Chemical Industries Plc N-disubstituted cycloalkylmethyl amines useful as fungicides
DE3801743A1 (de) * 1987-07-03 1989-01-19 Bayer Ag Schaedlingsbekaempfungsmittel auf basis von substituierten 1,4-naphthochinonen und neue substituierte 1,4-naphthochinone
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
GB8819477D0 (en) * 1988-08-16 1988-09-21 Wellcome Found Medicaments
AU633836B2 (en) * 1988-08-16 1993-02-11 Wellcome Foundation Limited, The Medicaments
US5225184A (en) * 1988-08-16 1993-07-06 Burroughs Wellcome Co. Medicaments
EP0567162A1 (en) * 1989-09-22 1993-10-27 The Wellcome Foundation Limited Medicaments for the treatment of toxoplasmosis
GB8921516D0 (en) * 1989-09-22 1989-11-08 Wellcome Found Medicaments
GB8923254D0 (en) * 1989-10-16 1989-12-06 Wellcome Found Medicaments
GB9126874D0 (en) * 1991-12-18 1992-02-19 Wellcome Found Medicaments
GB9207517D0 (en) * 1992-04-06 1992-05-20 Wellcome Found Heterocyclic compounds
GB9216859D0 (en) * 1992-08-07 1992-09-23 Wellcome Found Medicaments
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
US5856362A (en) * 1994-09-02 1999-01-05 Glaxo Wellcome Inc. Medicaments for the treatment of toxoplasmosis
AU2004320912A1 (en) * 2004-07-16 2006-04-27 Usv Limited Novel polymorphs of atovaquone and process of preparation thereof
BRPI0513951A (pt) * 2004-07-30 2008-05-20 Japan Health Science Found agente antiprotozoário
ITMI20070941A1 (it) * 2007-05-09 2008-11-10 Chimico Internazi0Nale S P A L Procedimento per la preparazione di naftochinoni trans2,3-disostituiti
CN101774901B (zh) * 2009-01-09 2012-10-03 武汉泰祥通生物技术有限公司 一种制备阿托伐醌的方法
EP2467358B1 (en) 2009-08-20 2014-07-23 IPCA Laboratories Limited Novel complex for treatment and/or prophylaxis of parasitic infections
GB2476644B (en) 2009-12-23 2012-11-14 Haomamedica Ltd 1,4-Dihydro-1,4-dioxonaphtalene derivatives for the treatment of osteoporosis
EP2651868A2 (en) 2010-12-15 2013-10-23 Glaxo Group Limited Process for the preparation of atovaquone
EP2845588A1 (en) * 2013-09-09 2015-03-11 Centre National de la Recherche Scientifique (C.N.R.S.) PIN1 inhibitors for use in the prevention and/or treatment of theileriosis, and related applications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2553647A (en) * 1946-03-20 1951-05-22 Research Corp Naphthoquinone antimalarials
EG14152A (en) * 1977-11-22 1983-12-31 Wellcome Found Antitheilerial naphtoquinone derivatives

Also Published As

Publication number Publication date
AU574353B2 (en) 1988-07-07
MX9202993A (es) 1992-07-01
IL71545A0 (en) 1984-07-31
IL71545A (en) 1987-12-20
DE19475021I2 (de) 2001-08-02
ZA842797B (en) 1985-11-27
DK193584A (da) 1984-10-15
PH22018A (en) 1988-05-13
AU2679684A (en) 1984-10-18
JPH0533212B2 (ja) 1993-05-19
EP0123238A2 (en) 1984-10-31
NL950002I2 (nl) 1998-04-01
EP0123238A3 (en) 1985-10-30
ATE27696T1 (de) 1987-06-15
DE3464132D1 (de) 1987-07-16
GB8310141D0 (en) 1983-05-18
LU88579I2 (fr) 1995-03-01
MY102117A (en) 1992-03-31
NL950002I1 (nl) 1995-03-01
SG39390G (en) 1990-11-23
HK56690A (en) 1990-08-03
DK193584D0 (da) 1984-04-13
DK172273B1 (da) 1998-02-16
EP0123238B1 (en) 1987-06-10
JPS59205341A (ja) 1984-11-20

Similar Documents

Publication Publication Date Title
EP0123238A3 (en) Naphthoquinone derivatives
IL62506A0 (en) Production of certain cephalosporin derivatives,novel intermediates for use therein and their production
JPS5776059A (en) Dimethine compounds from coumarins, manufacture and use as luminous dyestuffs
FI840953A (fi) Glasyr anvaendbar foer tandproteser av icke-metall.
HK59886A (en) After-treatment of dyeings made with disazo compounds
DE3564256D1 (en) Process for the preparation of alpha, alpha-difluoroalkyl phenyl ether derivatives
ES8205214A1 (es) Un procedimiento para la preparacion de un derivado de 3-o- desmetilsannamicina c o del antibiotico ax-127b-1.
JPS57198756A (en) Novel coumarin compound, manufacture and use as dye
AU3052684A (en) Phenyl ethanone derivatives and intermediates therefor
CA1265131C (en) ERYTHROMYCYLAMINE DERIVATIVES
JPS57192467A (en) Azo compound, manufacture and use as dye
ES464764A1 (es) Un procedimiento para preparar un compuesto de indol-dihi- droindoldionadimerico
JPS56147728A (en) Novel compound, its manufacture and use
JPS57185262A (en) Novel sulfenamide compound, manufacture and use as drug
SU999911A2 (ru) Кольцевой лазер
FR2251267A1 (en) Herbicidal compsns. - contg. 3-cyclo hexyl-5,6-trimethylene -uracil and 3-carbamoyloxy-acylanilines
ES8308334A1 (es) "proceso para la produccion de 5,3',4'-tridesoxi-6'-n-metilkanamicina b".
ZA815098B (en) Novel arylamine derivatives,production thereof and use thereof as microbicides
JPS5714592A (en) Cephalosporin derivatives,manufacture and composition containing them
PT74286A (en) Process for preparing phenyl substituted pyrido<1,4>benzodiaze-pines and intermediates therefor
ZA854497B (en) Process for the preparation of alpha,alpha-difluoroalkyl phenyl ether derivatives
JO1101B1 (en) Method for halogenation, reduction and preparation of emino halides cephalosporins or beta-lactam compounds
SU1248210A1 (ru) Производные циклогексан-1,3-дионов в качестве синергистов полового феромона яблонной плодожорки - транс-8, транс-10-додекадиен-1-ола
SU1150831A1 (ru) Машина непрерывного литья заготовок
FR2223005A1 (en) N-benzoyl-4-dialkylaminoethoxyanilines - antispasmodics etc